NCT04049188
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation Therapy
Key Eligibility Criteria:
Gender: All
Age: 18 Years to 100 Years   (Adult, Older Adult)
Location of Metastases: Bone
Additional Notes:
Exclusions:
https://ClinicalTrials.gov/show/NCT04049188